BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Satoh D, Yagi T, Nagasaka T, Shinoura S, Umeda Y, Yoshida R, Utsumi M, Tanaka T, Sadamori H, Fujiwara T. CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy. World J Hepatol 2013; 5(4): 189-195 [PMID: 23671723 DOI: 10.4254/wjh.v5.i4.189]
URL: https://www.wjgnet.com/1948-5182/full/v5/i4/189.htm
Number Citing Articles
1
Yuki Inagaki, Kiyoshi Fukunaga, Shinji Hashimoto, Keisuke Kohno, Tatsuya Oda, Nobuhiro Ohkohchi. A Case of Nonalcoholic Fatty Liver Disease with Hepatic Encephalopathy after Pancreatoduodenectomy, Which Improved Rapidly through Nutritional Care and Pancreatic Enzyme ReplacementThe Japanese Journal of Gastroenterological Surgery 2015; 48(4): 321 doi: 10.5833/jjgs.2014.0047
2
Pragyan Acharya, Komal Chouhan, Sabine Weiskirchen, Ralf Weiskirchen. Cellular Mechanisms of Liver FibrosisFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.671640
3
Parth Shah, Vanisha Patel, Motaz Ashkar. <i>De novo </i>non-alcoholic fatty liver disease after pancreatectomy: A systematic reviewWorld Journal of Clinical Cases 2022; 10(35): 12946-12958 doi: 10.12998/wjcc.v10.i35.12946
4
Shweta Kapil, Ajay Duseja, Bal Krishan Sharma, Bhupesh Singla, Anuradha Chakraborti, Ashim Das, Pallab Ray, Radha K Dhiman, Yogesh Chawla. Small intestinal bacterial overgrowth and toll‐like receptor signaling in patients with non‐alcoholic fatty liver diseaseJournal of Gastroenterology and Hepatology 2016; 31(1): 213 doi: 10.1111/jgh.13058
5
Kavin Sugumar, Lora Naik, Jonathan J. Hue, John B. Ammori, Jeffrey M. Hardacre, Lee M. Ocuin, Jordan M. Winter. Risk factors of developing nonalcoholic fatty liver disease after pancreatic resection: a systematic review and meta-analysisJournal of Gastrointestinal Surgery 2024; 28(6): 983 doi: 10.1016/j.gassur.2024.03.025
6
Vanisha Patel, Parth Shah, Daniel R. Ludwig, Chet W. Hammill, Motaz Ashkar. Development of de novo nonalcoholic fatty liver disease following pancreatectomyMedicine 2023; 102(4): e32782 doi: 10.1097/MD.0000000000032782
7
Rie Sato, Masashi Kishiwada, Naohisa Kuriyama, Yoshinori Azumi, Shugo Mizuno, Masanobu Usui, Hiroyuki Sakurai, Masami Tabata, Tomomi Yamada, Shuji Isaji. Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomyJournal of Hepato-Biliary-Pancreatic Sciences 2014; 21(8): 562 doi: 10.1002/jhbp.115
8
Shiori Shibata, Yuki Takahashi, Hideyuki Oyama, Yuzo Minegishi, Kuniya Tanaka. Incidence and clinical characteristics of hepatic steatosis following pancreatectomyThe Showa University Journal of Medical Sciences 2024; 36(1): 25 doi: 10.15369/sujms.36.25
9
Shifeng Fu, Mengmeng Xu, Jianglei Li, Meihong Yu, Siyi Wang, Liu Han, Rong Li, Feihong Deng, Hailing Peng, Deliang Liu, Yuyong Tan. HDAC6 inhibitor ACY-1215 protects from nonalcoholic fatty liver disease via inhibiting CD14/TLR4/MyD88/MAPK/NFκB signal pathwayHeliyon 2024; 10(13): e33740 doi: 10.1016/j.heliyon.2024.e33740
10
Tomotaka Mori, Eisuke Ozawa, Ryu Sasaki, Akane Shimakura, Kosuke Takahashi, Yoko Kido, Yasuko Kanda, Satoshi Matsuo, Kazuaki Tajima, Asami Beppu, Yasuhiko Nakao, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Tomohiko Adachi, Susumu Eguchi, Shinji Okano, Kazuhiko Nakao. Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy?JGH Open 2024; 8(6) doi: 10.1002/jgh3.13113
11
Tatsuo Hata, Masaharu Ishida, Fuyuhiko Motoi, Naoaki Sakata, Gumpei Yoshimatsu, Takeshi Naitoh, Yu Katayose, Shinichi Egawa, Michiaki Unno. Clinical Characteristics and Risk Factors for the Development of Postoperative Hepatic Steatosis After Total PancreatectomyPancreas 2016; 45(3): 362 doi: 10.1097/MPA.0000000000000462